InsidersTradesSigma
Follow the Agilent Technologies, INC. share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, Agilent Technologies, INC. has recorded 364 public disclosures. Market capitalisation: €37.1bn. The latest transaction was reported on 29 June 2026 (Retenue fiscale). Among the most active insiders: MCDONNELL PADRAIG. The full history is accessible without an account.
364
Insider Decl.
n/a
Thresholds
€272
2 ops.
Buy Volume
€55m
51 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Agilent Technologies, INC. Buy (bullish), based on 19 analysts. Average price target: US$159.32.
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,546 of 29,056 companies
56.9
score / 100
Value40
Quality74
FCF yld2.7%
Earn yld3.0%
EV/EBITDA25.5x
ROE21%
Gross mgn52%
Net mgn19%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
Declarations364 total
30 sharesCommon StockSEC:0001090872-26-000060:0
418 shares@ US$137.400.0001% mcap0.5% of flowCommon StockSEC:0001090872-26-000058:0
1,600 shares@ US$135.420.0005% mcap15.3% of flowCommon StockSEC:0001090872-26-000057:0
8,872 shares0Common StockSEC:0001090872-26-000046:0
153 shares@ US$113.98100.0% of flowCommon StockSEC:0001090872-26-000040:0
2,158 shares@ US$111.7511.1% of flowCommon StockSEC:0001090872-26-000039:0
2,158 shares@ US$111.7515.9% of flowCommon StockSEC:0001090872-26-000037:0
2,158 shares@ US$111.7513.7% of flowCommon StockSEC:0001090872-26-000036:0
2,158 shares@ US$111.7550.1% of flowCommon StockSEC:0001090872-26-000034:0
2,158 shares@ US$111.7519.5% of flowCommon StockSEC:0001090872-26-000033:0
2,158 shares@ US$111.7515.8% of flowCommon StockSEC:0001090872-26-000029:0
2,158 shares@ US$111.756.4% of flowCommon StockSEC:0001090872-26-000028:0
2,158 shares@ US$111.7515.6% of flowCommon StockSEC:0001090872-26-000027:0
2,158 shares@ US$111.7539.4% of flowCommon StockSEC:0001090872-26-000026:0
2,158 shares@ US$111.7519.5% of flowCommon StockSEC:0001090872-26-000024:0
124 shares@ US$121.382.6% of flowCommon StockSEC:0001090872-26-000020:0
279 shares@ US$121.380.3% of flowCommon StockSEC:0001090872-26-000021:0
89 shares@ US$121.381.2% of flowCommon StockSEC:0001090872-26-000022:0
2,600 shares@ US$149.81220.0% of flowCommon StockSEC:0001090872-25-000083:0
208 shares@ US$154.377.1% of flowCommon StockSEC:0001090872-25-000082:0
280 shares@ US$154.374.8% of flowCommon StockSEC:0001090872-25-000081:0
1,948 shares@ US$154.372.4% of flowCommon StockSEC:0001090872-25-000080:0
430 shares@ US$154.3710.4% of flowCommon StockSEC:0001090872-25-000078:0
25 of 364 declarations
关于 Agilent Technologies, INC.
Agilent Technologies, Inc. (NYSE: A) 是一家领先的美国实验室技术公司，在美国纽约证券交易所上市。从国际股权角度来看，鉴于其在制药、生物制药、诊断、学术、环境、食品和工业终端市场的强大影响力，安捷伦完全符合健康与制药行业的范畴。该公司于1999年5月在特拉华州注册成立，此前惠普剥离了其科学仪器业务，目前由加利福尼亚州圣克拉拉管理，为全球客户提供服务。([sec.gov](https://www.sec.gov/Archives/edgar/data/1090872/000109087225000087/a-20251031.htm?utm_source=openai)) 安捷伦的业务模式以实验室工作流程中的应用导向型解决方案为中心：仪器、软件、服务和耗材。根据2024年末宣布的组织变革，公司目前报告三个部门：生命科学和诊断市场、Agilent CrossLab和应用市场。生命科学和诊断市场包括液相色谱、LC/MS联用平台、病理学和伴随诊断。Agilent CrossLab包括耗材、实验室自动化、软件、信息学和相关服务。应用市场包括气相色谱、GC/MS、光谱学、再营销仪器和真空部门。([sec.gov](https://www.sec.gov/Archives/edgar/data/1090872/000109087225000087/a-20251031.htm?utm_source=openai)) 在竞争方面，安捷伦在高端分析仪器领域占据强势地位，这得益于庞大的装机量以及耗材、服务合同和软件带来的经常性收入。其差异化优势在于集成化、面向工作流程的产品组合，旨在提高实验室生产力、合规性和分析通量。这一市场定位使安捷伦与全球其他仪器领导者展开竞争，但在分析和临床工作流程方面具有显著的专业化。([sec.gov](https://www.sec.gov/Archives/edgar/data/1090872/000109087225000087/a-20251031.htm?utm_source=openai)) 主要产品和服务包括液相和气相色谱系统、LC/MS和GC/MS平台、病理学解决方案、伴随诊断、实验室耗材和翻新服务。最近的沟通还强调了更强的可持续性和循环经济角度，包括认证翻新中心、以旧换新计划以及旨在提高仪器连接性和实验室生产力的产品发布。([agilent.com](https://www.agilent.com/about/newsroom/presrel/2025/27may-ca25017.html?utm_source=openai)) 在地理上，安捷伦拥有真正的全球足迹，业务和服务遍及北美、欧洲和亚太地区。最近在澳大利亚、印度、新加坡、马来西亚和韩国的举措突显了管理层深化其在区域科学中心影响力的决心。在近期业绩方面，公司报告2026财年第一季度收入为1.80 billion美元，报告增长7.0%，核心增长4.4%，同时继续通过新的色谱、病理学和自动化产品扩展其产品组合。([agilent.com](https://www.agilent.com/about/newsroom/presrel/2026/25feb-gp26003.html?utm_source=openai))
